Oasis Diagnostics Corporation

Oasis Diagnostics Corporation Non-invasive saliva based technology for rapid testing, sample collection & molecular diagnostics

Oasis Diagnostics® Corporation was founded to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics.

For several years I have been honored to act as a Topic Editor for the high impact journal Clinical Therapeutics handlin...
04/20/2026

For several years I have been honored to act as a Topic Editor for the high impact journal Clinical Therapeutics handling most manuscripts related to diagnostic products, however recently I was asked if I would be interested in handling a “Specialty Update” for the journal. I immediately accepted this honor and opportunity so I’m very pleased to share that my Call for Papers is now open focusing on the following subject which is dear to my heart:

Circulating Biomarkers in Precision Diagnostics: Advancing Disease Detection Across Clinical Disciplines

Details:

We are inviting submissions from researchers and clinicians working across biomarker discovery, translational science, and precision diagnostics. This Specialty Update is intended to highlight advances that are shaping earlier detection, better monitoring, and more informed clinical decision-making across a range of disease areas using circulating biomarkers in any biological fluid [blood, plasma, CSF, saliva, tears, etc.].

Manuscript types may include:
• Original Research
• Review Articles
• Brief Reports
• Commentary
• Pilot Studies
• Case Reports

If your work is helping move precision diagnostics forward, I encourage you to consider submitting your manuscript for publication.

Please be sure to select: “VSI: Biomarkers in Precision Diagnostics” during the submission process so the manuscript is routed correctly.

The submission link and QR code are included in the banner below.

I would also appreciate it if you could share this with colleagues and collaborators who may be interested in contributing.

There is growing interest in what the mouth may be able to tell us about brain health long before more obvious symptoms ...
04/17/2026

There is growing interest in what the mouth may be able to tell us about brain health long before more obvious symptoms appear.

A recent article highlighted research exploring the link between oral pathogens, inflammation, and Alzheimer’s disease, including the possible role of Porphyromonas gingivalis and its toxic enzymes, gingipains.

While much more work still needs to be done, the broader signal is important: the mouth may provide early biological clues that reach far beyond oral health.

At Oasis, that is exactly why we remain so focused on saliva and oral sample collection.

If we want earlier insight, wider access, and more practical pathways to screening and monitoring, we need collection methods that are simple, non invasive, and easy to use across a wide range of settings.

The future of diagnostics will not be built on complexity alone. It will also be built on accessibility.

Saliva has an important role to play in that future.

Read article here: https://www.futura-sciences.com/en/before-memory-fades-the-mouth-warns-discover-this-early-alzheimers-signal_29481/

A recent story from Hackensack Meridian Health highlights something important: earlier cancer detection is no longer jus...
04/16/2026

A recent story from Hackensack Meridian Health highlights something important: earlier cancer detection is no longer just about finding disease sooner, it is increasingly about identifying risk before cancer fully develops. Their Hennessy Institute program combines a brief risk assessment with follow-up saliva-based genetic testing that can be completed from home, helping connect people to earlier screening and preventive care.

At Oasis Diagnostics, this is exactly why we believe saliva has such a powerful role in the future of healthcare.

When screening becomes easier, less invasive, and more accessible, more people can take action earlier. That matters not only for convenience, but for outcomes.

The more we reduce barriers to testing, the more we create opportunities for:
• earlier insight
• more proactive care
• better patient participation
• more scalable screening pathways

Saliva-based approaches are helping move diagnostics closer to where people are, making prevention and early detection more practical at scale.

That is the direction healthcare needs to keep moving.

Inspired by this article from Hackensack Meridian Health: “New Cancer Screening Tool Detects Cancer Sooner.”

A recent CNN article on daily life aboard Artemis II caught my attention, especially one detail: saliva collection is pa...
04/15/2026

A recent CNN article on daily life aboard Artemis II caught my attention, especially one detail: saliva collection is part of the mission’s health research.

Article: https://edition.cnn.com/2026/04/07/science/artemis-2-daily-life-in-space

It is a strong reminder that even in one of the most extreme environments imaginable, simple, practical specimen collection still matters.

Saliva plays an important role in overall health. It supports oral balance, helps with swallowing and digestion, contributes to antimicrobial defense, and can offer valuable biomarker insights for researchers studying human health. In settings like space, where access, simplicity, and repeatability are critical, those advantages become even more meaningful.

That is one reason saliva continues to gain attention across research and diagnostics.

At Oasis, we see this as part of a much bigger story: the future of testing is not just about discovering powerful biomarkers. It is also about making collection easier, more scalable, and more accessible wherever care, research, or monitoring needs to happen.

From clinics and homes to highly controlled research environments, smarter collection helps enable better science.

A recent Oral Health Group article put an important issue into focus during Oral Health Month: oral cancer awareness, pr...
04/14/2026

A recent Oral Health Group article put an important issue into focus during Oral Health Month: oral cancer awareness, prevention, and the role dental professionals play in early detection.

The article highlights Alberta’s “A Mouth Says A Lot” campaign and reminds us that routine dental visits are about far more than checking teeth. They are also an opportunity to examine the soft tissues of the mouth, tongue, cheeks, throat, lips, and surrounding areas for changes that may need closer attention.

It also points to a real awareness gap. Many patients understand that oral health is connected to overall health, yet fewer realize that oral cancer screening is already part of routine dental care. That matters, because earlier conversations, greater awareness, and regular checkups can help people act sooner when something does not feel right.

For Oasis Diagnostics, this is exactly why innovation in oral health matters. As the field continues to push for earlier detection and better patient access, saliva-based diagnostics represent part of a larger shift toward more comfortable, noninvasive, and scalable approaches to screening and testing.

Awareness starts the conversation.
Better diagnostics help move it forward.

Read the article here: https://www.oralhealthgroup.com/dental-industry/oral-cancer-awareness-in-focus-during-oral-health-month-as-dental-professionals-stress-prevention-1003994936/

It’s encouraging to see more dental practices bringing saliva testing into everyday patient care. 🦷Designer Dentistry & ...
04/08/2026

It’s encouraging to see more dental practices bringing saliva testing into everyday patient care. 🦷

Designer Dentistry & Smiles Sioux Falls recently highlighted its use of saliva testing through OralDNA Laboratories, positioning it as a simple, non-invasive way to identify bacterial risk, genetic risk for inflammatory disease, and HPV-related oral cancer risk, with results often available within about a week.

For Oasis Diagnostics, this is exactly the direction the field needs to keep moving.

The promise of saliva diagnostics has never been only about discovery. It is about making testing practical, accessible, and easy to integrate into real clinical workflows. When more providers begin using saliva to guide earlier detection, more personalized treatment, and follow-up monitoring, it reinforces the growing value of reliable front-end collection.

Saliva is simple to collect. The patient experience is easier. And the clinical opportunity continues to grow.💧

That is why building better infrastructure around saliva collection matters.

📖 Read more here: https://www.issuewire.com/designer-dentistry-smiles-sioux-falls-introduces-advanced-saliva-testing-technology-1861705591748532

The latest IADR Position and Policy Statement on Salivary Biology and Diagnostics is an important signal for our field. ...
04/07/2026

The latest IADR Position and Policy Statement on Salivary Biology and Diagnostics is an important signal for our field. Published on April 3, 2026, the statement recognizes saliva as an essential biological fluid in both oral and systemic health, and supports its use for diagnostics, disease monitoring, and evaluation of therapeutic outcomes.

What stands out is that IADR also points to a gap many of us have seen for years: despite strong evidence and clear advantages, salivary biology and diagnostics remain underutilized in clinical dentistry, underrepresented in translational research, and not yet fully integrated into public health frameworks. The statement also calls for practical, validated tools that support early detection and routine clinical use.

That is exactly why this work matters.

At Oasis Diagnostics, we see this as an important reminder that progress in saliva-based testing depends not only on biomarker discovery, but on practical, reliable collection tools that help bring research into real-world use. As the field pushes for greater standardization, earlier detection, and broader clinical adoption, the front end matters more than ever.

Saliva is simple, non-invasive, and cost-effective to collect. The opportunity is real. The infrastructure around it needs to be just as ready.

One of the most interesting parts of NASA’s Artemis II mission is not only where the crew is going, but what they are br...
04/06/2026

One of the most interesting parts of NASA’s Artemis II mission is not only where the crew is going, but what they are bringing into the science conversation: saliva.

NASA’s Immune Biomarkers work uses saliva collected before, during, and after the mission to study how deep space affects the immune system. Since Orion has tight volume constraints and cannot accommodate the refrigeration needed for wet samples, the crew uses dry saliva collection on specialized paper stored in pocket-sized booklets. NASA says these samples can help researchers evaluate stress-related changes, immune response, and even whether latent viruses reactivate during flight.

That is a powerful reminder of something we have believed for a long time at Oasis: saliva is far more than a convenient specimen. It is a practical, information-rich sample that can open the door to better, simpler, and more scalable testing.

When even a lunar mission depends on saliva because collection has to be simple, efficient, and low-burden, it says a lot about where the future of sample collection is heading. At Oasis, we see that future clearly — reliable saliva collection is not a niche idea. It is part of the infrastructure for next-generation diagnostics, wherever testing needs to happen.

Saliva liquid biopsy does not have to be complicated.At Oasis Diagnostics, we believe the front end of discovery matters...
04/03/2026

Saliva liquid biopsy does not have to be complicated.

At Oasis Diagnostics, we believe the front end of discovery matters just as much as the downstream analysis. When researchers want to isolate high value targets such as exosomes, cell free DNA, cell free RNA, and proteins from saliva, the collection method needs to be simple, standardized, and practical.

That is exactly where our Pure•SAL™ and RNAPro•SAL™ devices fit in.

Pure•SAL™ and RNAPro•SAL™ are two rapid non-invasive liquid biopsy platforms that support standardized collection workflows for cell free fractions [DNA, RNA], miRNA, and proteins. These devices remove interfering factors during the very short [3 Minute] collection process thereby simplifying sample collection to support the future growth of saliva in molecular and proteomic workflows.

One sample. Multiple analytes. Less collection friction.

For teams working across PCR, qPCR/dPCR, NGS, sequencing, proteomics, ELISA, and lateral flow applications, saliva offers a compelling path forward when the collection process is done right.

That is the opportunity.

Let’s play a quick game. 👇Guess the specimen:✔ Non-invasive✔ Easy to collect✔ Useful across a growing range of research ...
04/02/2026

Let’s play a quick game. 👇

Guess the specimen:

✔ Non-invasive
✔ Easy to collect
✔ Useful across a growing range of research and diagnostic applications
✔ Often underestimated

What is it?

You already know the answer. 😄
It’s saliva — and at Oasis, we think it deserves way more attention for the role it can play in expanding access, simplifying collection, and supporting the future of diagnostics.

Sometimes the most powerful tools are the ones people overlook.

It was a pleasure to finally meet Gary in person after we had been connected for several months. Gary is with PDS Health...
04/01/2026

It was a pleasure to finally meet Gary in person after we had been connected for several months. Gary is with PDS Health, formerly Pacific Dental Services, a major organization in the dental space that supports dentist-owned practices and has built a broad national footprint. It was great to connect, learn more about the work they are doing, and have the opportunity to continue building the relationship face to face.

Last week, I had the opportunity to attend the IADR/AADOCR meeting in San Diego, and it was an important event for Oasis...
03/31/2026

Last week, I had the opportunity to attend the IADR/AADOCR meeting in San Diego, and it was an important event for Oasis.

This meeting brings together many of the leading voices in dental, oral, and craniofacial research. For Oasis, it was especially significant because IADR continues to be a strong center of activity for salivary science, with researchers, clinicians, and innovators all helping shape the next generation of diagnostic testing.

What makes this community particularly compelling is that many dentists today are not only practitioners and researchers, but also entrepreneurial leaders. Many are actively involved in the development of new tests for lung and oral cancer, women’s health, liver fibrosis, and many other areas where better, earlier, and more accessible testing can make a real difference.

Several of our important collaborators and development partners were in attendance, so it was valuable to spend time together in person. It was also a great opportunity to connect with members of the Salivary Research Group and meet with researchers working on next-generation saliva-based tests, including some who are already Oasis customers.

Meetings like this are a strong reminder that Oasis is part of a much bigger movement. As saliva continues to gain recognition as a practical and powerful diagnostic specimen, it is exciting to see the science advancing and the community around it growing stronger.

Address

5920 NE 112th Avenue
Portland, OR
97220

Opening Hours

Monday 6am - 4pm
Tuesday 6am - 4pm
Wednesday 6am - 4pm
Thursday 6am - 4pm
Friday 6am - 4pm

Telephone

+13605461563

Website

Alerts

Be the first to know and let us send you an email when Oasis Diagnostics Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Oasis Diagnostics Corporation:

Shortcuts

Share

Category